Neil P. Robertson

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

Stephen Sawcer, Hywel B. Jones, Robert Feakes et al. · Nature Genetics · 1996 · 645 citations

Chromosome 6P21, Engineering, Genetic Disorder +8

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 511 citations · Full text

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Katharine Harding, Owain Williams, Mark Willis et al. · JAMA Neurology · 2019 · 342 citations · Full text

Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy

Orla Tuohy, Lisa Costelloe, Grant Hill-Cawthorne et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 238 citations · Full text

Age–adjusted recurrence risks for relatives of patients with multiple sclerosis

Neil P. Robertson, M Fraser, J. Deans et al. · Brain · 1996 · 232 citations · Full text

Disease Susceptibility, Disease Progression, Neurological Disorder +13